Dr Agarwals Eye Hospital share news, announcements and annual reports
NSE: DRAGARWQBSE: 526783Healthcare ServicesSmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹5,317.50.
2 Nov: open ₹5,318.50, high ₹5,460.00, low ₹5,221.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,615 Cr1,094th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.31
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 24.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,146
Dr Agarwals Eye Hospital share news and announcements
586 announcements, routine notices left out, newest first. Page 5 of 12.
Aug 2022
Jul 2022
25 Jul · Board meeting
Meeting on 4 Aug 2022: quarterly results19 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
May 2022
10 May · Business
Apr 2022
28 Apr · Board meeting
Meeting on 4 May 2022: audited results and final dividend22 Apr · Compliance Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations, 2015 For The Period From 01.04.2021 To 31.03.2022
21 Apr · Compliances- Compliance Certificate For The Year Ended 31St March 2022
19 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
Jan 2022
21 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....19 Jan · Board meeting
Meeting on 29 Jan 2022: quarterly results19 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021
22 Dec · Announcement Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
2 Dec · Legal
Exchange has sought clarification from Dr Agarwals Eye Hospital Ltd on December 2, 2021 with reference to significant movement in price, in order to ensure that investors have latest ....
Nov 2021
16 Nov · Disclosure Of Related Party Transaction For The Half Year Ended 30Th September, 2021.
Oct 2021
21 Oct · Board meeting
Meeting on 29 Oct 2021: quarterly results18 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 01 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2021
7 Sep · Reg. 34 (1) Annual Report
Jul 2021
20 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....15 Jul · Board meeting
Meeting on 23 Jul 2021: quarterly results13 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2021
4 May · Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation & Disclosure Requirements) Regulations, 2015